Abstract
Cardiac arrhythmia is 1 of the critical health conditions. Clofibrate is a peroxisome proliferated-activator receptor-α (PPAR-α) agonist that is widely used for reducing triglycerides in hyperlipidemic patients. Because this drug has showed several beneficial effects in relief of some cardiovascular diseases, the aim of the present study was to evaluate antiarrhythmic effects of clofibrate on ouabain-induced arrhythmia in rats.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
